Stelexis Therapeutics

Developer of small molecules to target pre‐cancerous stem cells

placeNew York City, New York, United States calendar_todayFounded 2017 groups7 employees language stelexis.com

Social engagement

Social engagement: 952 social following, 1 post in the last 12 months — below the industry typical range.

Coming soon